{"id":"W2156880046","doi":"10.1016/s0140-6736(03)13638-0","title":"Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial","year":2003,"lang":"en","type":"article","venue":"The Lancet","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":925,"is_retracted":false,"has_abstract":false,"ca_institutions":"Toronto General Hospital","funders":"Merck Sharp and Dohme; Novartis Pharma; Novartis","keywords":"Fluvastatin; Medicine; Clinical endpoint; Myocardial infarction; Placebo; Internal medicine; Population; Cardiology; Adverse effect; Randomized controlled trial; Simvastatin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01297410549041476,"score_gpt":0.2826195042277539,"score_spread":0.2696453987373392,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}